LAT Research   Report issue

For profit Phase 4
Founded: Buenos Aires Argentina (2010)

Organization Overview

First Clinical Trial
2011
NCT01549236
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

LAT Research

Active Ingredients

Drugs in Phase 4 Trials (1)

benznidazole (Rochagan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chagas Disease (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1